Health Sciences Acquisitions Corporation 2
If you purchased Health Sciences Acquisitions Corporation 2 securities and would like to join the action, please click "Join This Action" below.
HALPER SADEH LLP ANNOUNCES INVESTIGATION OF HEALTH SCIENCES ACQUISITIONS CORPORATION 2
July 8, 2022.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Health Sciences Acquisitions Corporation 2 (NASDAQ: HSAQ) and Orchestra BioMed™, Inc. is fair to Health Sciences shareholders.
The investigation concerns whether Health Sciences and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Health Sciences shareholders; and (2) disclose all material information necessary for Health Sciences shareholders to adequately assess and value the merger consideration. On behalf of Health Sciences shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.